Recombinant Human CPA3 Protein，His

The CPA3 protein, a member of the carboxypeptidase A family, has garnered significant interest in recent years due to its role in various physiological and pathological processes. Primarily expressed in mast cells, CPA3 is known for its distinctive enzymatic activity, which facilitates the cleavage of C-terminal amino acids from peptide and protein substrates. Research has indicated that CPA3 plays a critical role in modulating immune responses, particularly in allergic reactions and asthma, where mast cells are activated and release various mediators. Additionally, CPA3 is implicated in inflammatory conditions and has been associated with certain cancers, suggesting that it may serve as a potential biomarker or therapeutic target. The protein's unique structural features, including its zymogen form and active site, have prompted studies to fully elucidate its enzymatic mechanisms and regulation. By employing advanced techniques such as crystallography and molecular modeling, researchers aim to better understand CPA3's function at the molecular level, paving the way for innovative therapeutic interventions. As the field of proteomics expands, the exploration of CPA3 continues to reveal its multifaceted roles in health and disease, highlighting its importance in biomedical research and potential clinical applications. Overall, the ongoing investigation into CPA3 is not only enriching our understanding of mast cell biology but also opening new avenues for treatment strategies targeting allergic and inflammatory disorders.